<DOC>
	<DOCNO>NCT01466855</DOCNO>
	<brief_summary>This study test give topotecan directly blood vessel eye improve treatment retinoblastoma . This method refer `` selective intra-ophthalmic artery chemotherapy '' ( SIOAC ) . The goal study : - To find topotecan effective treatment retinoblastoma deliver directly ophthalmic artery ( SIOAC delivery ) - To find kind effect ( good bad ) expect topotecan give SIOAC - To assess visual pathway function study therapy - To learn pharmacology ( body handle drug ) topotecan deliver directly ophthalmic artery</brief_summary>
	<brief_title>A Study Intra-Ophthalmic Artery Topotecan Infusion Treatment Retinoblastoma</brief_title>
	<detailed_description />
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>1 . Age : 15 year age younger 2 . Diagnosis : Patients untreated Group C/D/E unilateral Retinoblastoma presentation without indication immediate enucleation ( neovascular glaucoma orbital pain ) ( Stratum A ) , patient history bilateral retinoblastoma recurrent and/or refractory intraocular retinoblastoma chemotherapy , external beam radiation and/or enucleation remain know option disease control ( Stratum B ) . 3 . Therapeutic Options : Chemotherapy , External Beam Radiation therapy and/or Enucleation 4 . Lansky ≥ 50 patient ≤ 10 year age ; Karnofsky ≥ 50 patient &gt; 10 year age . Patients unable walk paralysis , wheelchair , consider ambulatory purpose assess performance score . 5 . Prior Therapy : Stratum A : No prior therapy allow . Stratum B : Patients must local relapsed/refractory disease receive standard upfront therapy involve least one chemotherapeutic regimen . There limit prior chemotherapeutic regimen permit . Prior radiation therapy permit . 6 . Patients must recover acute toxic effect prior chemotherapy , immunotherapy , radiotherapy prior enter study , describe : Myelosuppressive chemotherapy : patient must receive myelosuppressive chemotherapy within 3 week study enrollment . Biologic therapy : Patients must receive biologic anticancer agent within one week study enrollment . Radiation therapy : Four week must elapse since external beam radiation therapy , give . 7 . Adequate Bone Marrow Function Defined : Peripheral absolute neutrophil count ( ANC ) great equal 750/uL Platelet count great equal 75,000/uL ( transfusion independent , define receive platelet transfusion within 7day period prior enrollment ) Hemoglobin great equal 8.0 gm/dL ( may receive RBC transfusion ) 8 . Adequate Renal Function Defined : Maximum serum creatinine base age follow : 1 &lt; 2 year 0.6 mg/dL ; 2 &lt; 6 year 0.8 mg/dL ; 6 &lt; 10 year 1 mg/dL ; 10 &lt; 13 year 1.2 mg/dL ; 13 15 year 1.5 mg/dL boy 1.4 mg/dL girl . OR Creatinine clearance radioisotope GFR great equal 70ml/min/1.73 m2 9 . Adequate Liver Function Defined As : Bilirubin ( sum conjugate + unconjugated ) less equal 1.5 x upper limit normal ( ULN ) age SGPT ( ALT ) less equal 5 x upper limit normal ( ULN ) age Serum albumin great equal 2 g/dL 10 . Informed Consent : All patient and/or parent legal guardian must sign write informed consent . Assent , appropriate , obtain accord institutional guideline . 11 . Patients childbearing potential must negative pregnancy test agree use effective birth control method ( abstinence acceptable form birth control ) . 1 . Extraocular retinoblastoma retinoblastoma involve anterior chamber 2 . Retinoblastoma could otherwise treat laser therapy , cryotherapy , plaque therapy 3 . Structural brain abnormality 4 . Uncontrolled infection , define require intravenous antibiotic time enrollment 5 . Concomitant Medications Growth factor support platelet white cell number function must administer within 3 day prior enrollment . Patients currently receive nonFDA approve drug , receive nonFDA approve drug within 7 day prior enrollment , ineligible . Patients currently receive anticancer agent ineligible . 6 . Patients opinion investigator may able comply safety monitoring requirement study eligible .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Retinoblastoma</keyword>
</DOC>